Posts

Glenmark and IADVL Launch Campaign to Support Vitiligo Patients in India

Glenmark & IADVL Release Special Cover in collaboration with Indian Postal Service Supporting Vitiligo Patients in India

Glenmark becomes the First Company in India to launch Teneligliptin + Dapagliflozin Fixed-Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities

'Glenmark' becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults